DIVA Laboratories, Ltd. (4153.TWO)

TWD 38.75

(-1.77%)

Gross Profit Summary of DIVA Laboratories, Ltd.

  • DIVA Laboratories, Ltd.'s latest annual gross profit in 2023 was 250.77 Million TWD , down -5.77% from previous year.
  • DIVA Laboratories, Ltd.'s latest quarterly gross profit in 2024 Q3 was 59.56 Million TWD , down -16.75% from previous quarter.
  • DIVA Laboratories, Ltd. reported a annual gross profit of 266.13 Million TWD in annual gross profit 2022, up 46.55% from previous year.
  • DIVA Laboratories, Ltd. reported a annual gross profit of 181.59 Million TWD in annual gross profit 2021, down -15.01% from previous year.
  • DIVA Laboratories, Ltd. reported a quarterly gross profit of 62.51 Million TWD for 2024 Q1, up 32.08% from previous quarter.
  • DIVA Laboratories, Ltd. reported a quarterly gross profit of 71.54 Million TWD for 2024 Q2, up 14.44% from previous quarter.

Annual Gross Profit Chart of DIVA Laboratories, Ltd. (2023 - 2019)

Historical Annual Gross Profit of DIVA Laboratories, Ltd. (2023 - 2019)

Year Gross Profit Gross Profit Growth
2023 250.77 Million TWD -5.77%
2022 266.13 Million TWD 46.55%
2021 181.59 Million TWD -15.01%
2020 213.66 Million TWD -4.97%
2019 224.84 Million TWD 0.0%

Peer Gross Profit Comparison of DIVA Laboratories, Ltd.

Name Gross Profit Gross Profit Difference
BIONET Corp. 638.27 Million TWD 60.711%
Genetics Generation Advancement Corp. 236.83 Million TWD -5.887%
Welgene Biotech Co.,Ltd. 119.71 Million TWD -109.473%
Puriblood Medical Co., Ltd. 6.52 Million TWD -3744.443%
TFBS Bioscience Inc. 77.82 Million TWD -222.21%